Market Introduction
Anaphylaxis is an allergic reaction that can further lead to a fatal condition known as anaphylactic shock. Anaphylaxis occurs when the patient's body reacts to a foreign substance and produces a high amount of histamine that triggers an inflammatory response. It is a severe, life threatening allergic reaction marked by indications such as swallowing and breathing difficulties, skin itching, and lowering blood pressure.
Thus, the rising incidence of anaphylaxis is expected to create a significant demand for anaphylaxis treatment in the coming years, which is further anticipated to drive the anaphylaxis treatment market.
Countries in the Middle East have also widely affected the socio-economic condition by the COVID–19 pandemic. However, the countries have wisely reacted to the COVID–19 pandemic to avoid the spread of infection. Similar to other regions, lockdown and social distancing were imposed, which has impaired these trends hindering access to work, regular income, payments, fairs, schools, and healthcare. Therefore, it is expected the countries have undergone huge losses and are still trying to recover them. Due to the less developed economies majority of the countries are depended on the suppliers of medical devices. In addition, there is high uncertainty of the spread of COVID-19 in Africa and other low-income countries such as Cameroon, Egypt, Algeria, Morocco, South Africa, Togo, Nigeria, Senegal, and Tunisia. Due to a widespread outbreak of COVID-19 in Africa, has led to disruption in healthcare services. However, the anaphylaxis treatment market in this pandemic is growing due to the increasing awareness about treatments of asthma and allergic diseases linked to viral infection in the region.
Market Overview and Dynamics
The Anaphylaxis treatment market in Middle East and Africa is expected to grow from US$ 52.2 million in 2021 to US$ 87.1 million by 2028; it is estimated to grow at a CAGR of 7.6% from 2021 to 2028. Novel drug delivery systems support improved drug potency and controlled drug release, along with imparting a sustained therapeutic effect for reliable safety. Many drugs have a maximum concentration range for maximum benefit, and concentrations above or below can be toxic or produce no medicinal use. Furthermore, various drug delivery and drug targeting systems are explained to have a capability of minimizing drug degradation as well as preventing harmful side effects. The intramuscular injection of epinephrine is normally underutilized when anaphylaxis occurs, mainly due to unavailability or unaffordability. Drugs provide the convenience of a wide range of pain-free multiple doses, particularly for children, if required, for out-of-hospital emergency treatment of anaphylaxis.
Key Market Segments
In terms of medication type, the epinephrine segment accounted for the largest share of the Middle East and Africa anaphylaxis treatment market in 2020. In terms of route of administration, the parenteral segment accounted for the largest share of the Middle East and Africa anaphylaxis treatment market in 2020. In terms of allergy type, the food allergy segment accounted for the largest share of the Middle East and Africa anaphylaxis treatment market in 2020. In terms of distribution channel, the retail pharmacies segment held a larger market share of the anaphylaxis treatment market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the anaphylaxis treatment market in Middle East and Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Amneal Pharmaceuticals Inc., Mylan N.V., Abbott, Pfizer Inc., Glaxosmithkline Plc., Merck and Co., Inc., Teva Pharmaceutical Industries Ltd., and ALK-ABELLó.
Reasons to buy report
MIDDLE EAST AND AFRICA ANAPHYLAXIS TREATMENT MARKET SEGMENTATION
By Medication Type
By Route of Administration
By Allergy Type
By Distribution Channel
By Country
Companies Mentioned
| Report Attribute | Details |
|---|---|
| Market size in 2021 | US$ 52.2 Million |
| Market Size by 2028 | US$ 87.1 Million |
| CAGR (2021 - 2028) | 7.6% |
| Historical Data | 2019-2020 |
| Forecast period | 2022-2028 |
| Segments Covered |
By Medication Type
|
| Regions and Countries Covered |
Middle East and Africa
|
| Market leaders and key company profiles |
|
The Middle East and Africa Anaphylaxis Treatment Market is valued at US$ 52.2 Million in 2021, it is projected to reach US$ 87.1 Million by 2028.
As per our report Middle East and Africa Anaphylaxis Treatment Market, the market size is valued at US$ 52.2 Million in 2021, projecting it to reach US$ 87.1 Million by 2028. This translates to a CAGR of approximately 7.6% during the forecast period.
The Middle East and Africa Anaphylaxis Treatment Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Anaphylaxis Treatment Market report:
The Middle East and Africa Anaphylaxis Treatment Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The Middle East and Africa Anaphylaxis Treatment Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the Middle East and Africa Anaphylaxis Treatment Market value chain can benefit from the information contained in a comprehensive market report.
Please tell us your area of interest
(Market Segments/ Regions and Countries/ Companies)
E 1803, Panchshil Towers,
Wagholi, Haveli,
Pune - 412207,
Maharashtra, India
US:+16467917070
sales@businessmarketinsights.com
Get Free Sample For Middle East and Africa Anaphylaxis Treatment Market
